Pathogenesis of Paget's disease of bone

Bone

Volumn 43, Issue 5, 2008, Pages 819-825

  Ralston, Stuart H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Genetic; Osteoblast; Osteoclast; Paget's disease; RANK

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P62; PROTEIN P97; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; VIRUS PROTEIN;

BONE DISEASE; BONE PAIN; CALCIUM INTAKE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; NERVE COMPRESSION; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; PAGET BONE DISEASE; PATHOLOGIC FRACTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SQSTM1 GENE; VIRUS INFECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BONE AND BONES; HUMANS; MUTATION; OSTEITIS DEFORMANS; OSTEOCLASTS; OSTEOPROTEGERIN; POLYMORPHISM, GENETIC; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION;

EID: 53349165206     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.06.015     Document Type: Review

References (114)

1. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
2. Alvarez L., Peris P., Guanabens N., Vidal S., Ros I., Pons F., et al. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Arthritis Rheum. 48 (2003) 824-828
3. Basle M.F., Fournier J.G., Rozenblatt S., Rebel A., and Bouteille M. Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J. Gen. Virol. 67 Pt 5 (1986) 907-913
4. Beneton M.N.C., Harris S., and Kanis J.A. Paramyxovirus-like inclusions in two cases of pycnodysostosis. Metab. Bone Dis. Rel. Res. 8 (1987) 211-217
5. Beyens G., Daroszewska A., de F.F., Fransen E., Vanhoenacker F., Verbruggen L., et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J. Bone Miner. Res. 22 (2007) 1062-1071
6. Bhadada S., Bhansali A., Unnikrishnan A.G., Khadgawat R., Singh S.K., Mithal A., et al. Does Paget's disease exist in India?: a series of 21 patients. J. Assoc. Physicians India 54 (2006) 530-534
7. Bianco P., Silvestrini G., Ballanti P., and Bonucci E. Paramyxovirus-like nuclear inclusions identical to those of Paget's disease of bone detected in giant cells of primary oxalosis. Virchows Archiv - A, Pathological Anatomy & Histopathology 421 (1992) 427-433
8. Birch M.A., Ginty A.F., Walsh C.A., Fraser W.D., Gallagher J.A., and Bilbe G. PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J. Bone Miner. Res. 8 (1993) 1155-1162
9. Birch M.A., Taylor W., Fraser W.D., Ralston S.H., Hart C.A., and Gallagher J.A. Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J. Bone Miner. Res. 9 (1994) 11-16
10. Cavey J.R., Ralston S.H., Sheppard P.W., Ciani B., Gallagher T.R., Long J.E., et al. Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone. Calcif. Tissue Int. 78 (2006) 271-277
11. Ciani B., Layfield R., Cavey J.R., Sheppard P.W., and Searle M.S. Structure of the UBA domain of p62 (SQSTM1) and implications for mutations which cause Paget's disease of bone. J. Biol. Chem. 278 (2003) 37409-37412
12. Cody J.D., Singer F.R., Roodman G.D., Otterund B., Lewis T.B., Leppert M., et al. Genetic linkage of Paget disease of the bone to chromosome 18q. Am. J. Hum. Genet. 61 (1997) 1117-1122
13. Collet C., Michou L., Audran M., Chasseigneaux S., Hilliquin P., Bardin T., et al. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J. Bone Miner. Res. 22 (2007) 310-317
14. Cooper C., Schafheutle K., Dennison E., Kellingray S., Guyer P., and Barker D. The epidemiology of Paget's disease in Britain: is the prevalence decreasing?. J. Bone Miner. Res. 14 (1999) 192-197
15. Cundy H.R., Gamble G., Wattie D., Rutland M., and Cundy T. Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif. Tissue Int. 75 (2004) 358-364
16. Cundy T., Hegde M., Naot D., Chong B., King A., Wallace R., et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum. Mol. Genet. 11 (2002) 2119-2127
17. Daroszewska A., Hocking L.J., McGuigan F., Langdahl B.L., Stone M.D., Cundy T., et al. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. Journal of Bone & Mineral Research 19 (2004) 1506-1511
18. Demulder A., Takahashi S., Singer F.R., Hosking D.J., and Roodman G.D. Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. Endocrinology 133 (1993) 1978-1982
19. Detheridge F.M., Guyer P.B., and Barker D.J. European distribution of Paget's disease of bone. Br. Med. J. 285 (1982) 1005-1008
20. Duran A., Serrano M., Leitges M., Flores J.M., Picard S., Brown J.P., et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6 (2004) 303-309
21. Eekhoff E.W., Karperien M., Houtsma D., Zwinderman A.H., Dragoiescu C., Kneppers A.L., et al. Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum. 50 (2004) 1650-1654
22. Falchetti A., Di Stefano M., Marini F., Del Monte F., Mavilia C., Strigoli D., et al. Two novel mutations at exon 8 of Sequestosome 1 gene (SQSTM1) in an Italian series of patients affected by Paget's disease of bone (PDB). J. Bone Miner. Res. 19 (2004) 1013-1017
23. Feng Y., and Longmore G.D. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex. Mol. Cell Biol. 25 (2005) 4010-4022
24. Feng Y., Zhao H., Luderer H.F., Epple H., Faccio R., Ross F.P., et al. The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development. J. Biol. Chem. 282 (2007) 39-48
25. Friedrichs W.E., Reddy S.V., Bruder J.M., Cundy T., Cornish J., Singer F.R., et al. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J. Bone Miner. Res. 17 (2002) 145-151
26. Friedrichs W.E., Reddy S.V., Singer F.R., and Roodman G.D. The Pro and Con of Measles Virus in Paget's Disease: Pro. J. Bone Miner. Res. 17 (2002) 2293
27. Good D.A., Busfield F., Fletcher B.H., Duffy D.L., Kesting J.B., Andersen J., et al. Linkage of Paget disease of bone to a novel region on human chromosome 18q23. Am. J. Hum. Genet. 70 (2001) 517-525
28. Good D.A., Busfield F., Fletcher B.H., Lovelock P.K., Duffy D.L., Kesting J.B., et al. Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 35 (2004) 277-282
29. Gordon M.T., Anderson D.C., and Sharpe P.T. Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12 (1991) 195-201
30. Gordon M.T., Mee A.P., Anderson D.C., and Sharpe P.T. Canine distemper transcripts sequenced from pagetic bone. Bone and Mineral 19 (1992) 159-174
31. Haslam S.I., Van Hul W., Morales-Piga A., Balemans W., San Millan J.L., Nakatsuka K., et al. Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J. Bone Miner. Res. 13 (1998) 911-917
32. Helfrich M.H., Hobson R.P., Grabowski P.S., Zurbriggen A., Cosby S.L., Dickson G.R., et al. A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J. Bone Miner. Res. 15 (2000) 2315-2329
33. Hocking L., Slee F., Haslam S.I., Cundy T., Nicholson G., Van H.W., et al. Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q. Bone 26 (2000) 577-580
34. Hocking L.J., Herbert C.A., Nicholls R.K., Williams F., Bennett S.T., Cundy T., et al. Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am. J. Hum. Genet. 69 (2001) 1055-1061
35. Hocking L.J., Lucas G., Daroszewska A., Cundy T., Nicholson G.C., Donath J., et al. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis and structural consequences. J. Bone Miner. Res. 19 (2004) 1122-1127
36. Hocking L.J., Lucas G., Daroszewska A., Mangion J., Olavesen M., Nicholson G.C., et al. Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Human Molecular Genetics 11 (2002) 2735-2739
37. Hoyland J.A., Freemont A.J., and Sharpe P.T. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J. Bone Miner. Res. 9 (1994) 75-80
38. Hoyland J.A., and Sharpe P.T. Up-regulation of c-fos protooncogene expression in pagetic osteoclasts. J. Bone Miner. Res. 8 (1994) 1191-1195
39. Hughes A.E., Ralston S.H., Marken J., Bell C., MacPherson H., Wallace R.G., et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat. Genet. 24 (2000) 45-48
40. Hughes A.E., Shearman A.M., Weber J.L., Barr R.J., Wallace R.G., Osterberg P.H., et al. Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum. Mol. Genet. 3 (1994) 359-361
41. Hutchison III C.A. DNA sequencing: bench to bedside and beyond. Nucleic Acids Res. 35 (2007) 6227-6237
42. Johnson-Pais T.L., Wisdom J.H., Weldon K.S., Cody J.D., Hansen M.F., Singer F.R., et al. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J. Bone Miner. Res. 18 (2003) 1748-1753
43. Khan S.A., Brennan P., Newman J., Gray R.E., McCloskey E.V., and Kanis J.A. Paget's disease of bone and unvaccinated dogs. Bone 19 (1996) 47-50
44. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131 (2007) 1149-1163
45. Kovach M.J., Waggoner B., Leal S.M., Gelber D., Khardori R., Levenstien M.A., et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 74 (2001) 458-475
46. Kukita A., Chenu C., McManus L.M., Mundy G.R., and Roodman G.D. Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease. J. Clin. Invest. 85 (1990) 1280-1286
47. Kurihara N., Hiruma Y., Zhou H., Subler M.A., Dempster D.W., Singer F.R., et al. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J. Clin. Invest. 117 (2007) 133-142
48. Kurihara N., Reddy S.V., Araki N., Ishizuka S., Ozono K., Cornish J., et al. Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J. Bone Miner. Res. 19 (2004) 1154-1164
49. Kurihara N., Reddy S.V., Menaa C., Anderson D., and Roodman G.D. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J. Clin. Invest. 105 (2000) 607-614
50. Langston A.L., Campbell M.K., Fraser W.D., Maclennan G., Selby P., and Ralston S.H. Clinical determinants of quality of life in Paget's disease of bone. Calcif. Tissue Int. 80 (2007) 1-9
51. Laurin N., Brown J.P., Lemainque A., Duchesne A., Huot D., Lacourciere Y., et al. Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am. J. Hum. Genet. 69 (2001) 528-543
52. Laurin N., Brown J.P., Morissette J., and Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70 (2002) 1582-1588
53. Layfield R., Alban A., Mayer R.J., and Lowe J. The ubiquitin protein catabolic disorders. Neuropathol. Appl. Neurobiol. 27 (2001) 171-179
54. Lucas G., Riches P., Hocking L., Cundy T., Nicholson G., Walsh J., et al. Identification of a major locus for Paget disease on chromosome 10p13 in families of British descent. J. Bone Miner. Res. 23 (2008) 58-63
55. Lucas G.J., Daroszewska A., and Ralston S.H. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. J. Bone Miner. Res. 21 Suppl 2 (2006) 31-37
56. Lucas G.J., Mehta S.G., Hocking L.J., Stewart T.L., Cundy T., Nicholson G.C., et al. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 38 (2006) 280-285
57. Marco-Mingot M., San-Millan J.L., Wuyts W., Bachiller-Corral J., Van H.W., and Morales-Piga A.A. Lack of mutations in the RANK gene in Spanish patients with Paget disease of bone. Clin. Genet. 60 (2001) 86-88
58. Martini G., Gennari L., Merlotti D., Salvadori S., Franci M.B., Campagna S., et al. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone. Bone 40 (2007) 457-463
59. Matthews B.G., Afzal M.A., Minor P.D., Bava U., Callon K.E., Pitto R.P., et al. Failure to detect measles virus RNA in bone cells from patients with Paget's disease. J. Clin. Endocrinol. Metab. (2008)
60. McKenna M.J., Mills B.G., Galey F.R., and Linthicum Jr. F.H. Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am. J. Otol. 7 (1986) 25-28
61. Mee A.P., Dixon J.A., Hoyland J.A., Davies M., Selby P.L., and Mawer E.B. Detection of canine distemper virus in 100% of Paget's disease samples by in situ-reverse transcriptase polymerase chain reaction. Bone 23 (1998) 171-175
62. Mee A.P., May C., Bennett D., and Sharpe P.T. Generation of multinucleated osteoclast-like cells from canine bone marrow: effects of canine distemper virus. Bone 17 (1995) 47-55
63. Menaa C., Reddy S.V., Kurihara N., Maeda H., Anderson D., Cundy T., et al. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J. Clin. Invest. 105 (2000) 1833-1838
64. Meunier P.J., Coindre J.M., Edouard C.M., and Arlot M.E. Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum. 23 (1980) 1095-1103
65. Mills B.G., Frausto A., Singer F.R., Ohsaki Y., Demulder A., and Roodman G.D. Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens. Bone 15 (1994) 443-448
66. Mills B.G., and Singer F.R. Nuclear inclusions in Paget's disease of bone. Science 194 (1976) 201-202
67. Mills B.G., Singer F.R., Weiner L.P., and Holst P.A. Immunohistological demonstration of respiratory syncytial virus antigens in Paget's disease of bone. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 1209-1212
68. Mills B.G., Singer F.R., Weiner L.P., Suffin S.C., Stabile E., and Holst P. Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin. Orthop. Rel. Res. 183 (1984) 303-311
69. Mills B.G., Yabe H., and Singer F.R. Osteoclasts in human osteopetrosis contain viral-nucleocapsid-like nuclear inclusions. J. Bone Miner. Res. 3 (1988) 101-106
70. Montagu M. Paget's disease (osteitis deformans) and hereditary. Am. J. Hum. Genet. 1 (1949) 94-95
71. Morales-Piga A.A., Rey-Rey J.S., Corres-Gonzalez J., Garcia-Sagredo J.M., and Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 10 (1995) 663-670
72. Moscat J., and Diaz-Meco M.T. The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies. Adv. Enzyme Regul. 42 (2002) 173-179
73. Mossetti G., Rendina D., De F.G., Viceconti R., Di D.G., Cioffi M., et al. Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment. Bone 36 (2005) 549-554
74. Nagy Z.B., Gergely P., Donath J., Borgulya G., Csanad M., and Poor G. Gene expression profiling in Paget's disease of bone: upregulation of interferon signaling pathways in pagetic monocytes and lymphocytes. J. Bone Miner. Res. 23 (2008) 253-259
75. Nakatsuka K., Nishizawa Y., and Ralston S.H. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J. Bone Miner. Res. 18 (2003) 1381-1385
76. Naot D., Bava U., Matthews B., Callon K.E., Gamble G.D., Black M., et al. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J. Bone Miner. Res. 22 (2007) 298-309
77. Natale V.M., Filho W.J., and Duarte A.J. Cellular immunity aspects in elderly subjects with Paget's disease of bone. Calcif. Tissue Int. 60 (1997) 410-414
78. Neale S.D., Smith R., Wass J.A., and Athanasou N.A. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone 27 (2000) 409-416
79. Nuovo M.A., Nuovo G.J., MacConnell P., Forde A., and Steiner G.C. In situ analysis of Paget's disease of bone for measles-specific PCR-amplified cDNA. Diagnostic Molecular Pathology 1 (1992) 256-265
80. O'Driscoll J.B., and Anderson D.C. Past pets and Paget's disease. Lancet 2 (1985) 919-921
81. Ooi C.G., Walsh C.A., Gallagher J.A., and Fraser W.D. Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27 (2000) 417-421
82. Osterberg P.H., Wallace R.G., Adams D.A., Crone R.S., Dickson G.R., Kanis J.A., et al. Familial expansile osteolysis. A new dysplasia. J. Bone Joint Surg. Br. 70 (1988) 255-260
83. Ralston S.H., Afzal M.A., Helfrich M.H., Fraser W.D., Gallagher J.A., Mee A., et al. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J. Bone Miner. Res. 22 (2007) 569-577
84. Ralston S.H., DiGiovine F.S., Gallacher S.J., Boyle I.T., and Duff G.W. Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J. Bone Miner. Res. 6 (1991) 1243-1248
85. Ralston S.H., Hoey S.A., Gallacher S.J., Adamson B.B., and Boyle I.T. Cytokine and growth factor expression in Paget's disease: analysis by reverse-transcription/polymerase chain reaction. Br. J. Rheumatol. 33 (1994) 620-625
86. Rea S.L., Walsh J.P., Ward L., Yip K., Ward B.K., Kent G.N., et al. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. J. Bone Miner. Res. 21 (2006) 1136-1145
87. Rebel A., Basle M., Pouplard A., Malkani K., Filmon R., and Lepatezour A. Bone tissue in Paget's disease of bone. Ultrastructure and immunocytology. Arth. Rheum. 23 (1980) 1104-1114
88. Rebel A., Malkani K., Basle M., Bregeon C., Patezour A., and Filmon R. Ultrastructural characteristics of osteoclasts in Paget's disease. Rev. Rhum. Mal. Osteoartic. 41 (1974) 767-771
89. Rebel A., Malkani K., Basle M., and Bregeon C. Particularites ultrastructurales des osteoclasts de la maladie de Paget. Rev. Rhum. Mal. Osteoartic 41 (1974) 767-771
90. Reddy S.V., Kurihara N., Menaa C., Landucci G., Forthal D., Koop B.A., et al. Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts. Endocrinology 142 (2001) 2898-2905
91. Reddy S.V., Menaa C., Singer F.R., Cundy T., Cornish J., Whyte M.P., et al. Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp. Hematol. 27 (1999) 1528-1532
92. Rendina D., Gennari L., De F.G., Merlotti D., de C.E., Fazioli F., et al. Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J. Bone Miner. Res. 21 (2006) 1828-1835
93. Rhodes E.C., Johnson-Pais T.L., Singer F.R., Ankerst D.P., Bruder J.M., Wisdom J., et al. Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States. Calcif. Tissue Int (2008)
94. Rima B.K., Gassen U., Helfrich M.H., and Ralston S.H. The pro and con of measles virus in Paget's disease: con. J. Bone Miner. Res. 17 (2002) 2290-2292
95. Rojas J.A., Daroszewska A., Helfrich M., Layfield R., van't Hof R., and Ralston S.H. Mice with a truncation mutation affecting sequestosome 1 exhibit several phenotypic features in common with Paget's disease of bone. Calcif. Tiss. Int. 81 (2007) 149
96. Roodman G.D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., et al. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J. Clin. Invest 89 (1992) 46-52
97. Ruddle N.H., Li C.B., Horne W.C., Santiago P., Troiano N., Jay G., et al. Mice transgenic for HTLV-I LTR-tax exhibit tax expression in bone, skeletal alterations, and high bone turnover. Virology 197 (1993) 196-204
98. Seibenhener M.L., Babu J.R., Geetha T., Wong H.C., Krishna N.R., and Wooten M.W. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 24 (2004) 8055-8068
99. Siris E.S., Kelsey J.L., Flaster E., and Parker S. Paget's disease of bone and previous pet ownership in the United States: dogs exonerated. Int.J Epidemiol. 19 (1990) 455-458
100. Siris E.S., Ottman R., Flaster E., and Kelsey J.L. Familial aggregation of Paget's disease of bone. J. Bone Miner. Res. 6 (1991) 495-500
101. Sofaer J.A., Holloway S.M., and Emery A.E. A family study of Paget's disease of bone. J. Epidemiol. Community Health 37 (1983) 226-231
102. Sun S.G., Lau Y.S., Itonaga I., Sabokbar A., and Athanasou N.A. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. J. Pathol. 209 (2006) 114-120
103. Takata S., Hashimoto J., Nakatsuka K., Yoshimura N., Yoh K., Ohno I., Yabe H., et al. Guidelines for diagnosis and management of Paget's disease of bone in Japan. J. Bone Miner. Metab. 24 (2006) 359-367
104. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 (2002) 744-749
105. Tiegs R.D., Lohse C.M., Wollan P.C., and Melton L.J. Long-term trends in the incidence of Paget's disease of bone. Bone 27 (2000) 423-427
106. Tilyard M.W., Gardner R.J., Milligan L., Cleary T.A., and Stewart R.D. A probable linkage between familial Paget's disease and the HLA loci. Australian & New Zealand Journal of Medicine 12 (1982) 498-500
107. van Staa T.P., Selby P., Leufkens H.G., Lyles K., Sprafka J.M., and Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J. Bone Miner. Res. 17 (2002) 465-471
108. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36 (2004) 377-381
109. Weihl C.C., Dalal S., Pestronk A., and Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 15 (2006) 189-199
110. Whyte M.P., and Hughes A.E. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J. Bone Miner. Res. 17 (2002) 26-29
111. Whyte M.P., Mills B.G., Reinus W.R., Podgornik M.N., Roodman G.D., Gannon F.H., et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J. Bone Miner. Res. 15 (2000) 2330-2344
112. Whyte M.P., Obrecht S.E., Finnegan P.M., Jones J.L., Podgornik M.N., McAlister W.H., et al. Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347 (2002) 175-184
113. Wuyts W., Van Wesenbeeck L., Morales-Piga A., Ralston S., Hocking L., Vanhoenacker F., et al. Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28 (2001) 104-107
114. Yip K.H., Feng H., Pavlos N.J., Zheng M.H., and Xu J. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone. Am. J. Pathol. 169 (2006) 503-514